Skip to Content
Jump to the top of the page

William Blair has been made aware of fraudulent activity involving individuals impersonating our employees and brand, including through fake websites and messaging apps like WhatsApp and Telegram. If you have any questions or concerns about someone from William Blair contacting you, please reach out to us via our Contact Us form. Please note — William Blair will never initiate contact with you via messaging apps.

William Blair Thinking

  • The Quarterly Rx: Q2 2025 U.S. Biopharma Recap

    The second quarter was another rollercoaster period for biopharma, opening with “Liberation Day” and closing amid mounting macro and geopolitical uncertainty.

    Read more
  • Non-U.S. Investing In a Fragmenting World

    Our global equity team believes the conditions underpinning more than a decade of non-U.S. equity underperformance may be starting to shift.

    Read more
  • Economics Weekly: Midyear Update: Resiliency Amid Uncertainty

    In this Economics Weekly, Richard de Chazal presents a midyear update, with a review and preview of the first and second halves of 2025.

    Read more

Our Mission, Vision, and Values

At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.

Learn more about our mission, vision, and values

Global Community Partners

We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.

More about our community partners

Our Latest News

  • Beekeeper Has Agreed to be Acquired by LumApps

    William Blair acted as the exclusive financial advisor to Beekeeper in connection with its pending acquisition by LumApps, a portfolio company of Bridgepoint.

    Read more
  • Dianthus Therapeutics, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Dianthus Therapeutics, Inc. (DNTH $18.63), a clinical-stage biotech company focused on developing novel therapeutics for autoimmune neuromuscular conditions.

    Read more
  • James Hardie Industries plc: Initiation of Research Coverage

    William Blair initiated research coverage of James Hardie Industries plc (JHX $25.77), the No. 1 global manufacturer of high-performance fiber cement siding and cement backer boards used primarily in residential markets.

    Read more

Join Our Team

Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.

Search our job openings
Women sitting outside with a laptop

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures